The Best Argument Against Kidney Sales Fails

Journal of Medical Ethics 41 (6):443-446 (2015)
  Copy   BIBTEX

Abstract

Simon Rippon has recently argued against kidney markets on the grounds that introducing the option to vend will result in many people, especially the poor, being subject to harmful pressure to vend. Though compelling, Rippon’s argument fails. What he takes to be a single phenomenon—social and legal pressure to vend—is actually two. Only one of these forms of pressure is, by Rippon’s own account, harmful. Further, an empirically informed view of the regulated market suggests that this harmful pressure is easily avoided. Thus, the harm that is the lynchpin of Rippon’s opposition is neither a necessary feature of the market nor is it likely to play a signicant role in its operation.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,937

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2015-09-03

Downloads
29 (#774,799)

6 months
9 (#485,111)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Luke Semrau
Bloomsburg University

Citations of this work

The Quantified Relationship.John Danaher, Sven Nyholm & Brian D. Earp - 2018 - American Journal of Bioethics 18 (2):3-19.
Choice, pressure and markets in kidneys.Julian Koplin - 2018 - Journal of Medical Ethics 44 (5):310-313.

View all 10 citations / Add more citations